Oral Vaccines Market SWOT Analysis Of Top Key Player Forecasts To 2025

Vaccination is termed as a cost-effective and efficient means of preventing various infectious disorders. The use of common vaccines has curbed the widespread transmission of diseases such as polio and measles in developing as well as developed regions. Oral vaccines exhibit the potential to take immunization to a new level of excellence. Although most vaccines are delivered via the parenteral route, oral vaccines are considered to be a feasible & cost-effective alternative employed for the prevention of non-mucosal transmitted infections. Orally administered vaccines are processed by the digestive tract’s immune system, referred to as the gut-associated lymphoid tissue (GALT). To increase immunity against vital disorders such as influenza and tuberculosis (TB), new oral vaccines are being produced in developed countries.

Elimination of needles in the vaccination process and their safe & cost effective nature are driving the oral vaccines market remarkably. The rising prevalence of infectious diseases in developing countries, resistance to existing vaccines, and bioterrorism are some of the factors expected to push the market from 2017 to 2025. However, oral vaccination is considered to be less effective compared to vaccines administered via parenteral routes, as in the former method, antigens undergo digestion in the gastrointestinal tract prior to the induction of immune response. This could restrain the market over the forecast period.

View Report @ http://www.transparencymarketresearch.com/oral-vaccines-market.html

The global oral vaccines market can be segmented on the basis of vaccine type into the live (attenuated), inactive, recombinant, and other varieties. The inactive segment accounted for a major chunk of the market revenue in 2016 due to its safety and cost-effectiveness. It is likely to remain dominant over the forecast period owing to the expanding patient pool in national immunization programs.

Based on application, the global oral vaccines market is divided into the following categories: polio, rabies, tuberculosis, influenza, respiratory infections, HIV, cholera, rotavirus, and others. The influenza and HIV segments constituted a major portion of the revenue in 2016, due to their rising prevalence in developing countries. Oral vaccines for tuberculosis, HIV, and influenza are projected to dominate the market over the forecast period due to their increasing development by key players and comparatively lower cost.

By end-user, the global oral vaccines market is split into the following groups: hospitals, government vaccination programs, clinics, and research institutes. Clinics and government vaccination programs held major market shares in 2016, which is attributed to the government participation in the prevention and treatment of infectious disorders in developing countries and rising investments by key players in R&D of invention of better and efficient medication. Government vaccination programs are estimated to remain dominant in the market by 2025 due to the resistance of the population for existing vaccines and favorable government reimbursement schemes.

Geographically, the global oral vaccines market is distributed over North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America captured a prominent market share in 2016 owing to the high purchasing power of the region’s population to afford costly vaccines and the periodical mass immunization programs held by the government. The need to avoid the risk of contamination by needles & syringes and recent USFDA approvals for oral vaccines for infectious diseases such as tuberculosis & cholera are estimated to propel the oral vaccines market in North America during the forecast period. However, Asia Pacific is expected to witness a significant CAGR on account of the rising incidence of HIV and influenza in developing countries.

Major players operating in the global oral vaccines market include GlaxoSmithKline Plc., Merck & Co. Inc., Aventis (Sanofi S.A.), Swiss Serum and Vaccine Institute Berne, QUÍMICA SUIZA S.A., PaxVax Corporation, VALNEVA Canada Inc., Janssen Pharmaceuticals, Serum Institute of India Pvt. Ltd., and Shanghai BravoBio Co., Ltd. Presently, a limited number of oral vaccines has been approved by regulatory authorities for human use and many more are in their later stages of clinical trials.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Get accurate market forecast and analysis on the Oral Vaccines market. Request a sample to stay abreast on the key trends impacting this market.

http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=24041

The study is a source of reliable data on:

Market segments and sub-segments

Market trends and dynamics

Supply and demand

Market size

Current trends/opportunities/challenges

Competitive landscape

Technological breakthroughs

Value chain and stakeholder analysis

The regional analysis covers:

North America (U.S. and Canada)

Latin America (Mexico, Brazil, Peru, Chile, and others)

Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)

Eastern Europe (Poland and Russia)

Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)

Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

A complete backdrop analysis, which includes an assessment of the parent market

Important changes in market dynamics

Market segmentation up to the second or third level

Historical, current, and projected size of the market from the standpoint of both value and volume

Reporting and evaluation of recent industry developments

Market shares and strategies of key players

Emerging niche segments and regional markets

An objective assessment of the trajectory of the market

Recommendations to companies for strengthening their foothold in the market

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

Designed by CyFocus.com
Powered by CyFocus.net